In addition, the relationships between different EC states and different brain tumour behaviours and treatment responses should be clarified, as they may contribute to the poor efficacy of anti‐endothelial therapy with single anti‐VEGF agents. The gene discussed is VEGFA; the disease is brain neoplasm.